GeoVax, Inc. Report issue

For profit Phase 1
Founded: Atlanta GA United States (2001)

Organization Overview

First Clinical Trial
2010
NCT01378156
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

GeoVax Labs, Inc

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 1)

Infections (Phase 1)

Vaccinia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 7